Alvotech Announces Approval in Japan of AVT04 (ustekinumab), a Biosimilar to Stelara® tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Shares of Alvotech (ALVO have increased by 4% on Monday following news that its commercialization partner in Japan, Fuji Pharma Co., Ltd., has received approval to market AVT04 (ustekinumab), a biosimilar to Stelara, from the Japanese Ministry of Health, Labor and Welfare.
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
05.09.2023 - Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, and Fuji Pharma Co., Ltd. (“Fuji”) . Seite 1
VistaGen Therapeutics (VTGN) and Fuji Enter Exclusive Negotiations for a Potential License to Develop and Commercialize Vistagen s PH80 in Japan streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.